PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Population-Level Bioethics, Rutgers University, New Brunswick, NJ, USA; Rutgers Biomedical and Health Sciences, Newark, NJ, USA. Electronic address: steuwer@cplb.rutgers.edu.\', \'Ethox Centre and Wellcome Centre for Ethics and Humanities, University of Oxford, Oxford, UK; Monash Bioethics Centre, Monash University, Melbourne, Australia; Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia. Electronic address: zeb.jamrozik@monash.edu.\', \'Center for Population-Level Bioethics, Rutgers University, New Brunswick, NJ, USA; Department of Philosophy, Rutgers University, New Brunswick, NJ, USA; Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, NJ, USA. Electronic address: neyal@cplb.rutgers.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1201-9712(21)00124-710.1016/j.ijid.2021.02.038
?:doi
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33592338
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all